These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 11057868

  • 1. Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats.
    Hérault JP, Perrin B, Jongbloet C, Pflieger AM, Bernat A, Herbert JM.
    Thromb Haemost; 2000 Oct; 84(4):668-74. PubMed ID: 11057868
    [Abstract] [Full Text] [Related]

  • 2. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 3. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S, Samama MM.
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):207-14. PubMed ID: 19657318
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
    Hara T, Yokoyama A, Tanabe K, Ishihara H, Iwamoto M.
    Thromb Haemost; 1995 Aug; 74(2):635-9. PubMed ID: 8584999
    [Abstract] [Full Text] [Related]

  • 7. Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
    Wong PC, Quan ML, Crain EJ, Watson CA, Wexler RR, Knabb RM.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):351-7. PubMed ID: 10604970
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase.
    Hérault JP, Bernat A, Pflieger AM, Lormeau JC, Herbert JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):16-22. PubMed ID: 9336303
    [Abstract] [Full Text] [Related]

  • 9. Factor Xa inhibitors: today and beyond.
    Walenga JM, Jeske WP, Hoppensteadt D, Fareed J.
    Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
    [Abstract] [Full Text] [Related]

  • 10. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J.
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [Abstract] [Full Text] [Related]

  • 11. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.
    Hara T, Yokoyama A, Ishihara H, Yokoyama Y, Nagahara T, Iwamoto M.
    Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795
    [Abstract] [Full Text] [Related]

  • 12. Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.
    Zafar MU, Farkouh ME, Osende J, Shimbo D, Palencia S, Crook J, Leadley R, Fuster V, Chesebro JH.
    Thromb Haemost; 2007 Mar; 97(3):487-92. PubMed ID: 17334518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of prothrombinase activity by protein S.
    van 't Veer C, Butenas S, Golden NJ, Mann KG.
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA, Needle SJ, Burns-Kurtis CL, Valocik RE, Koster PF, Amour AJ, Chan C, Brown D, Chaudry L, Zhou P, Patikis A, Patel C, Pateman AJ, Young RJ, Watson NS, Toomey JR.
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):66-71. PubMed ID: 18645410
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors.
    Hauptmann J, Kaiser B, Nowak G, Stürzebecher J, Markwardt F.
    Thromb Haemost; 1990 Apr 12; 63(2):220-3. PubMed ID: 2363124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor.
    Iwatsuki Y, Sato T, Moritani Y, Shigenaga T, Suzuki M, Kawasaki T, Funatsu T, Kaku S.
    Eur J Pharmacol; 2011 Dec 30; 673(1-3):49-55. PubMed ID: 22040919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.